Maximal entropy inference of oncogenicity from phosphorylation signaling

T G Graeber1, J R Heath, B J Skaggs

  • 1Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, Los Angeles, CA 90095, USA.

Insights

Point mutations in Bcr-Abl oncogenes cause drug resistance in chronic myelogenous leukemia. Information theory predicts leukemic transformation potency by analyzing phosphorylation events and identifying key signaling constraints.

Area of Science:

  • Biochemistry
  • Systems Biology
  • Oncology

Background:

  • Point mutations in the Bcr-Abl fusion oncogene's phosphorylation domain are linked to drug resistance in chronic myelogenous leukemia (CML).
  • These mutations impact kinase-mediated signaling pathways and cellular transformation.
  • Understanding these signaling alterations is crucial for developing effective CML therapies.

Purpose of the Study:

  • To apply information theory to correlate phosphoproteomic profiles with the transformation potency of Bcr-Abl mutants.
  • To develop a predictive model for leukemic transformation based on observed signaling patterns.
  • To identify critical phosphorylation events and signaling constraints that drive oncogenic phenotypes.

Main Methods:

  • Utilized an information theoretic approach to analyze phosphoproteomic data.
  • Constructed a maximal entropy distribution of site-specific phosphorylation events.
  • Quantified the relevance of signaling constraints by measuring entropy reduction.
  • Applied the developed theory to experimental phospho-proteomics data from kinase inhibitor-resistant Bcr-Abl mutants.

Main Results:

  • Identified a single dominant constraint significantly correlating phosphorylation events with oncogenic potency.
  • Demonstrated that this constraint effectively predicts trends in phenotypic output.
  • Found that other identified constraints were less relevant to the overall oncogenic potency.
  • Observed an additional constraint that may explain biological fine structure in signaling.

Conclusions:

  • A dominant signaling constraint in Bcr-Abl mutants largely predicts their leukemic transformation potency.
  • This information theoretic framework provides a powerful tool for systems biology analysis of high-throughput omics data.
  • The findings offer insights into drug resistance mechanisms and potential therapeutic targets in CML.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...